UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Cornerstone Wealth Advisors Inc.

Cornerstone Wealth Advisors Inc. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,418 shares of the healthcare conglomerate’s stock after purchasing an additional 33 shares during the period. UnitedHealth Group comprises 0.4% of Cornerstone Wealth Advisors Inc.’s portfolio, making the stock its 25th largest holding. Cornerstone Wealth Advisors Inc.’s holdings in UnitedHealth Group were worth $1,232,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Delos Wealth Advisors LLC lifted its position in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the period. True Wealth Design LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth about $31,000. Red Tortoise LLC boosted its holdings in UnitedHealth Group by 45.1% during the first quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock worth $36,000 after buying an additional 23 shares during the last quarter. Ruedi Wealth Management Inc. boosted its holdings in UnitedHealth Group by 58.3% during the first quarter. Ruedi Wealth Management Inc. now owns 76 shares of the healthcare conglomerate’s stock worth $38,000 after buying an additional 28 shares during the last quarter. Finally, Transcendent Capital Group LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $7.48 during trading on Friday, reaching $558.76. 2,976,835 shares of the company traded hands, compared to its average volume of 4,283,194. The company has a quick ratio of 0.85, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $591.54. The firm has a market capitalization of $514.27 billion, a PE ratio of 34.15, a PEG ratio of 1.58 and a beta of 0.59. The company’s 50 day moving average is $521.83 and its two-hundred day moving average is $504.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same period in the prior year, the company earned $6.14 EPS. UnitedHealth Group’s revenue for the quarter was up 6.4% on a year-over-year basis. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.50%. UnitedHealth Group’s payout ratio is 51.34%.

Insider Activity

In related news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on UNH. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Tuesday, July 23rd. Piper Sandler boosted their price target on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. HSBC boosted their price target on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Finally, Royal Bank of Canada boosted their target price on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.